001     128310
005     20240228145538.0
024 7 _ |a 10.1016/j.crad.2017.05.017
|2 doi
024 7 _ |a pmid:28687167
|2 pmid
024 7 _ |a 0009-9260
|2 ISSN
024 7 _ |a 1365-229X
|2 ISSN
024 7 _ |a altmetric:23398382
|2 altmetric
037 _ _ |a DKFZ-2017-04327
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Bickelhaupt, S.
|0 P:(DE-He78)d2d971750bce6217eb90fff9b01e61f9
|b 0
|u dkfz
245 _ _ |a Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography.
260 _ _ |a Amsterdam
|c 2017
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1509717128_12189
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a To investigate an abbreviated, contrast-agent free diffusion-weighted (DW) breast magnetic resonance imaging (MRI) protocol that provides a single image for the radiologist to read in order to non-invasively examine Breast Imaging-Reporting and Data System (BI-RADS) 4 lesions detected using breast cancer screening X-ray mammography.This retrospective evaluation within a institutional review board-approved, prospective study included 115 women (mean 57 years, range 50-69 years) with BI-RADS 4 findings on X-ray mammography and indication for biopsy over a period of 15 months. Full diagnostic breast MRI (FDP) was performed prior to biopsy (1.5 T). Maximum intensity breast diffusion (MIBD) images were generated from DW images (b = 1,500 mm/s(2), 3 mm section thickness) of the breast. MIBD and T2-weighted (T2W) images were read by two radiologists and compared to the diagnostic accuracy of an expert reading of the FDP with histopathology as the reference standard. The acquisition time of MIBD and T2W MRI was about 7 minutes.MIBD MRI provided a diagnostic accuracy of 87.93% (95% confidence interval [CI]: 80.58-93.24%) for R1 and 89.66% (95% CI: 82.63-94.54%) for R2. Expert reading of the FDP revealed a similar accuracy of 86.2% (95% CI: 78.67-91.43%). The positive predictive value (PPV) could be increased from 36.2% (95% CI: 28.02-45.28; X-ray mammography alone) to a mean PPV of 80.89% (R1 79.17%, R2 82.16%) using MIBD MRI. Mean reading time was 30 seconds (25%/75 percentile 24.5-41.25).MIBD MRI might be of supplemental value if added to the work-up of BI-RADS 4 X-ray mammography screening findings. MIBD MRI might help reduce the false-positive rate prior to biopsy for reference lesions at only limited expense of measurement and reading time.
536 _ _ |a 315 - Imaging and radiooncology (POF3-315)
|0 G:(DE-HGF)POF3-315
|c POF3-315
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Paech, D.
|0 P:(DE-He78)c6e31fb8f19e185e254174554a0cccfc
|b 1
|u dkfz
700 1 _ |a Laun, Frederik
|0 P:(DE-He78)b709e6df1ec6b63e5ffad4c8131f6f4d
|b 2
|u dkfz
700 1 _ |a Steudle, F.
|0 P:(DE-He78)b03f7e5246e8a54dc8b9664fa11324e2
|b 3
|u dkfz
700 1 _ |a Kuder, T. A.
|0 P:(DE-He78)59dfdd0ee0a7f0db81535f0781a3a6d6
|b 4
|u dkfz
700 1 _ |a Mlynarska, A.
|0 P:(DE-He78)f2017cf9c3356b8a6babaa5943f1e99e
|b 5
|u dkfz
700 1 _ |a Bach, M.
|0 P:(DE-He78)8dc01b0de0431cb7eced92277c1f04c7
|b 6
|u dkfz
700 1 _ |a Lederer, W.
|b 7
700 1 _ |a Teiner, S.
|b 8
700 1 _ |a Schneider, S.
|b 9
700 1 _ |a Ladd, Mark
|0 P:(DE-He78)022611a2317e4de40fd912e0a72293a8
|b 10
|u dkfz
700 1 _ |a Daniel, H.
|b 11
700 1 _ |a Stieber, A.
|b 12
700 1 _ |a Kopp-Schneider, A.
|0 P:(DE-He78)bb6a7a70f976eb8df1769944bf913596
|b 13
|u dkfz
700 1 _ |a Delorme, S.
|0 P:(DE-He78)3e76653311420a51a5faeb80363bd73e
|b 14
|u dkfz
700 1 _ |a Schlemmer, H-P
|0 P:(DE-HGF)0
|b 15
|e Last author
773 _ _ |a 10.1016/j.crad.2017.05.017
|g Vol. 72, no. 10, p. 900.e1 - 900.e8
|0 PERI:(DE-600)2002588-9
|n 10
|p 900.e1 - 900.e8
|t Clinical radiology
|v 72
|y 2017
|x 0009-9260
909 C O |o oai:inrepo02.dkfz.de:128310
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)d2d971750bce6217eb90fff9b01e61f9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)c6e31fb8f19e185e254174554a0cccfc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)b709e6df1ec6b63e5ffad4c8131f6f4d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)b03f7e5246e8a54dc8b9664fa11324e2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)59dfdd0ee0a7f0db81535f0781a3a6d6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)f2017cf9c3356b8a6babaa5943f1e99e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)8dc01b0de0431cb7eced92277c1f04c7
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)022611a2317e4de40fd912e0a72293a8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)bb6a7a70f976eb8df1769944bf913596
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)3e76653311420a51a5faeb80363bd73e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-315
|2 G:(DE-HGF)POF3-300
|v Imaging and radiooncology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2017
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN RADIOL : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)E010-20160331
|k E010
|l Radiologie
|x 0
920 1 _ |0 I:(DE-He78)E020-20160331
|k E020
|l Medizinische Physik in der Radiologie
|x 1
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E010-20160331
980 _ _ |a I:(DE-He78)E020-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21